Polypharmacy or medication washout: an old tool revisited

References

• NASMHPD Medical Directors’ Technical Report on Psychiatric Polypharmacy92001National Association of State Mental Health Program Directors Medical Directors Council and State Medicaid Directors Available from: http://www.nasmhpd.org/general_files/publications/med_directors_pubs/PolypharmacyAccessed Septemeber 18, 2011
   Google Scholar
• KingsburySJYiDSimpsonGMPsychopharmacology: rational and irrational polypharmacyPsychiatr Serv20015281033103611474046
   PubMed Web of Science ®Google Scholar
• Texas Department of Aging and Disability ServicesPolypharmacy definition developed by DADS Pharmacy Services52009 Available from: http://www.dads.state.tx.us/qualitymatters/qcp/polypharmacyAccessed August 14, 2011
   Google Scholar
• StroupTSMcEvoyJPSwartzMSTheNational Institute of Mental HealthClinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol developmentSchizophr Bull20032911531
   Google Scholar
• RushAJFavaMWisniewskiSRSTAR*D Investigators GroupSequenced treatment alternatives to relieve depression (STAR*D): rationale and designControl Clin Trials200425111914215061154
   PubMedGoogle Scholar
• GoldbergJFBrooksJO3rdKuritaKDepressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BDJ Clin Psychiatry200970215516219210946
   PubMed Web of Science ®Google Scholar
• DePauloJRBipolar disorder treatment: an evidence-based reality checkAm J Psychiatry2006163217517616449464
   PubMed Web of Science ®Google Scholar
• WatanabeNOmoriIMNakagawaASafety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysisCNS Drugs2010241355320030418
   PubMed Web of Science ®Google Scholar
• CiprianiALa FerlaTFurukawaTASertraline versus other antidepressive agents for depressionCochrane Database Syst Rev2009152CD00611719370626
   PubMedGoogle Scholar
• NakagawaAWatanabeNOmoriIMEfficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants: a systematic review and meta-analysisCNS Drugs200822758760218547127
   PubMed Web of Science ®Google Scholar
• CiprianiAGeddesJRFurukawaTABarbuiCMetareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practiceCan J Psychiatry200752955356217953159
   PubMed Web of Science ®Google Scholar
• InselTRDisruptive insights in psychiatry: transforming a clinical disciplineJ Clin Invest2008119470070519339761
   PubMed Web of Science ®Google Scholar
• WoodsSWMorgensternHSaksaJRIncidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort studyJ Clin Psychiatry201071446347420156410
   PubMed Web of Science ®Google Scholar
• GreenbergGInside the battle to define mental illnessWired12011
   Google Scholar
• MojtabaiROlfsonMNational patterns in antidepressant treatment by psychiatrists and general medical providers: results from the national comorbidity survey replicationJ Clin Psychiatry20086971064107418399725
   PubMed Web of Science ®Google Scholar
• GaynesBRushATrivediMThe STAR*D study: Treating depression in the real worldCleve Clin J Med2008751576618236731
   PubMed Web of Science ®Google Scholar
• FavaGATombaEGrandiSThe road to recovery from depression – don’t drive today with yesterday’s mapPsychother Psychosom200776526026517700045
   PubMed Web of Science ®Google Scholar
• GhaemiSNWhy antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depressionBipolar Disord200810395796819594510
   PubMed Web of Science ®Google Scholar
• PigottHELeventhalAMAlterGSBorenJJEfficacy and effectiveness of antidepressants: current status of researchPsychother Psychosom201079526727920616621
   PubMed Web of Science ®Google Scholar
• PigottHESTAR*D: A tale and trail of biasEthical Hum Psychol Psychiatry2011131628
   Google Scholar
• FryeMAKetterTALeverichGSThe increasing use of polypharmacotherapy for refractory mood disorders: 22 years of studyJ Clin Psychiatry200061191510695639
   PubMed Web of Science ®Google Scholar
• MojtabaiROlfsonMNational trends in psychotropic medication polypharmacy in office-based psychiatryArch Gen Psychiatry2010671263620048220
   PubMed Web of Science ®Google Scholar
• GundersonJGClinical practice. Borderline personality disorderN Engl J Med2011364212037204221612472
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHStewartJWCombining Medications to Enhance Depression Outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized studyAm J Psychiatry2011168768970121536692
   PubMed Web of Science ®Google Scholar
• YuryCAFisherJEAntonuccioDOValensteinMMatuszakJMeta- analysis of antidepressant augmentation: piling on in the absence of evidenceEthical Hum Psychol Psychiatry2009113171182
   Google Scholar
• Van BruntDLGibsonPJRamseyJLObenchainROutpatient use of major antipsychotic drugs in ambulatory care settings in the United States 1997–2000Med Gen Med20035316
   Google Scholar
• Mark TamiLFor what diagnoses are psychotropic medications being prescribed? A nationally representative survey of physiciansCNS Drugs201024431932620297856
   PubMed Web of Science ®Google Scholar
• KrystalJHRosenheckRACramerJAAdjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trialJAMA2011306549350221813427
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.govA review of clinical trials on the website Available from http://www.clinicaltrials.gov/ct2/results?term=atypical+antipsychotics/Accessed October 10, 2011. Accessed March 11, 2011
   Google Scholar
• NardoJMThe girdOne Boring Old Man Blog Available from: http://1boringoldman.com/index.php/2011/01/04/the-grid/Accessed February 18, 2011
   Google Scholar
• NelsonCJPapakostasGIAtypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trialsAm J Psychiatry2009166998099119687129
   PubMed Web of Science ®Google Scholar
• HajjarERCafieroACHanlonJTPolypharmacy in elderly patientsAm J Geriatr Pharmacother20075434535118179993
   PubMedGoogle Scholar
• GurvichTCunninghamJAAppropriate use of psychotropic drugs in nursing homesAm Fam Physician20006151437144610735348
   PubMed Web of Science ®Google Scholar
• FeilDWeinrebJSultzerDPsychiatric disorders and psychotropic medication use in elderly persons with diabetesAnn Longterm Care20061473947
   Google Scholar
• Nicole DamestoyNCollinJLalandeRPrescribing psychotropic medication for elderly patients: some physicians’ perspectivesCMAJ1999161214314510439822
   PubMed Web of Science ®Google Scholar
• MontamatSCCusackBOvercoming problems with polypharmacy and drug misuse in the elderlyClin Geriatr Med1992811431581576572
   PubMedGoogle Scholar
• GorenJLParksJJGhinassiFAWhen is antipsychotic polypharmacy supported by research evidence? Implications for QIJt Comm J Qual Patient Saf2008341057158218947117
   PubMedGoogle Scholar
• CentorrinoFGorenJLHennenJSalvatorePKelleherJPBaldessariniRJMultiple vs single antipsychotic agents for hospitalized psychiatric patients: Case-control study of risks versus benefitsAm J Psychiatry2004161470070615056517
   PubMed Web of Science ®Google Scholar
• JoukamaaMHeliovaaraMKnektPAromaaARaitasaloRLehtinenVSchizophrenia, neuroleptic medication and mortalityBr J Psychiatry200618812212716449697
   PubMed Web of Science ®Google Scholar
• WaddingtonJLYoussefHAKinsellaAMortality in schizophrenia: Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective studyBr J Psychiatry19981733253299926037
   PubMed Web of Science ®Google Scholar
• KingsburyLPsychiatric polypharmacy: the good, the bad, and the uglyPsychiatr Times200724413
   Google Scholar
• WanamakerJohnUS department store merchant 1838–1922 Available from: http://en.wikipedia.org/wiki/John_WanamakerAccessed April 14, 2011
   Google Scholar
• HelwickCPolypharmacy is common in psychiatry, but is more better?Medscape Medical News Available from: http://www.medscape.com/viewarticle/728132Accessed
   Google Scholar
• DaoJCareyBFroshDFor some troops, powerful drug cocktails have deadly resultsNew York Times2122011 Available from: http://www.nytimes.com/2011/02/13/us/13drugs.html?ref=benedictcareyAccessed September 16, 2011
   Google Scholar
• PreskornSHLaceyRLPolypharmacy: when is it rational?J Psychiatr Pract20071329710517414685
   PubMedGoogle Scholar
• HoffmanDADeBattistaCSchillerMMedication washout: imposing discontinuation or a diagnostic and therapeutic tool?Poster 230 presented at the US Psychiatric and Mental Health CongressSan Diego, CAOctober 30–November 2, 2008
   Google Scholar
• DeBattistaCKinrysGHoffmanDThe use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depressionJ Psychiatr Res2011451647520598710
   PubMed Web of Science ®Google Scholar
• GrunebaumMFOquendoMABurkeAKClinical impact of a 2 week psychotropic medication washout in unipolar depression inpatientsJ Affect Disord200375329129612880942
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry2006163111905191717074942
   PubMed Web of Science ®Google Scholar
• HoffmanDAFirst, do no harm – a basic tenet in jeopardy?J Neurother20071045361
   Google Scholar
• PatelJKGreenAIKalinowskiATsuangMTEvaluation of a complex case: the value of a drug washout periodAm J Psychiatry199715412174717509396956
   PubMed Web of Science ®Google Scholar
• VigueraACBaldessariniRJHegertyJDvan KammenDPTohenMClinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatmentArch Gen Psychiatry199754149559006400
   PubMed Web of Science ®Google Scholar
• Ascher-SvanumHFariesDEZhuBErnstFRSwartzMSSwansonJWMedication adherence and long-term functional outcomes in the treatment of schizophrenia in usual careJ Clin Psychiatry200667345346016649833
   PubMed Web of Science ®Google Scholar
• NovickDHaroJMSuarzeDPerezVDittmannRWHaddadPMPredictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophreniaPsychiatry Res20101762–310911320185182
   PubMed Web of Science ®Google Scholar
• DuttaRMurrayRMAllardyceJJonesPBBoydellJEarly risk factors for suicide in an epidemiological first episode psychosis cohortSchizophr Res20111261–3111921183318
   PubMed Web of Science ®Google Scholar
• FriedmanRMalonePRules of the Road: A Plaintiff Lawyer’s Guide to Proving Liability2nd edPortland, ORTrial Guides LLC2010
   Google Scholar